Your browser doesn't support javascript.
loading
Multiple Copies of qnrA1 on an IncA/C2 Plasmid Explain Enhanced Quinolone Resistance in an Escherichia coli Mutant.
Vinué, Laura; Sater, Mohamad R A; Herriott, Ian; Huntley, Miriam H; Jacoby, George A; Hooper, David C.
Afiliación
  • Vinué L; Massachusetts General Hospital, Boston, Massachusetts, USA lvinue-santolalla@mgh.haravard.edu.
  • Sater MRA; Day Zero Diagnostics, Boston, Massachusetts, USA.
  • Herriott I; Day Zero Diagnostics, Boston, Massachusetts, USA.
  • Huntley MH; Day Zero Diagnostics, Boston, Massachusetts, USA.
  • Jacoby GA; Lahey Hospital and Medical Center, Burlington, Massachusetts, USA.
  • Hooper DC; Massachusetts General Hospital, Boston, Massachusetts, USA.
Article en En | MEDLINE | ID: mdl-31160282
ABSTRACT
In a previous study, mutants with enhanced ciprofloxacin resistance (Cipr) were selected from Escherichia coli J53/pMG252 carrying qnrA1 Strain J53 Cipr 8-2 showed an increase in the copy number and transcription level of qnrA1 We sequenced the plasmids on Illumina and MinION platforms. Parental plasmid pMG252 and plasmid pMG252A from strain J53 Cipr 8-2 were almost identical, except for the region containing qnrA1 that in pMG252A contained 4 additional copies of the qnrA1-qacEΔ1-sul1-ISCR1 region.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Quinolonas / Proteínas de Escherichia coli / Escherichia coli / Antibacterianos Idioma: En Revista: Antimicrob Agents Chemother Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Quinolonas / Proteínas de Escherichia coli / Escherichia coli / Antibacterianos Idioma: En Revista: Antimicrob Agents Chemother Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos